Movatterモバイル変換


[0]ホーム

URL:


Eurekaselect logo
Bentham Newsletternewsletter banner
Login
Login

Forgot Your Password? New around here? Sign up
Register Cart 0
Generic placeholder image

Current Pharmaceutical Design

Editor-in-Chief

ISSN (Print): 1381-6128
ISSN (Online): 1873-4286

Chronic Inflammatory Diseases: Progress and Prospect with Herbal Medicine

Author(s):Nilanjan Ghosh,Asif Ali,Rituparna Ghosh,Shaileyee Das,Subhash C. Mandal andMahadeb Pal

Volume 22, Issue 2, 2016

Page: [247 - 264]Pages: 18

DOI:10.2174/1381612822666151112151419

Price: $65

TIMBC 2025
Abstract

Diseases associated with chronic inflammatory pathology claim a major share of worldwide deaths each year. A principal reasonbehind the huge number of casualties is associated with mild or unnoticed symptoms for long period of time since the outset, and thatspecific treatment options for these diseases have not yet emerged. Current anti-inflammatory drugs essentially have become ineffectivefor long term protection from these diseases as they also interfere with essential cellular pathways and associated toxicities. Notably, recentstudies with a number of phytochemicals have shown promising results. These compounds isolated from various medicinal plantsexpress their anti-inflammatory activities by down regulating expression of several crucial pro-inflammatory mediators. These are mostlyantioxidants; inhibit induction of key transcription factors like nuclear factor kappa B (NF-κB) that are responsible for expression of proinflammatorymediators, and other growth regulators. Definitely, some of these compounds have the potential to be developed into newtherapeutic agents to better control inflammation associated diseases in near future. This review summarizes recent findings on the molecularmechanisms through which various inflammatory activities are linked to disease progression and a group of natural products thathave shown promise in controlling these processes.

Keywords:Inflammation, natural products, nuclear factor kappa B (NF-κB), toll like receptor (TLR), cytokines, interleukin.


Rights & PermissionsPrintCite

Current Pharmaceutical Design

Title:Chronic Inflammatory Diseases: Progress and Prospect with Herbal Medicine

Volume: 22Issue: 2

Author(s):Nilanjan Ghosh, Asif Ali, Rituparna Ghosh, Shaileyee Das, Subhash C. Mandal and Mahadeb Pal

Affiliation:

              Keywords:Inflammation, natural products, nuclear factor kappa B (NF-κB), toll like receptor (TLR), cytokines, interleukin.

              Abstract: Diseases associated with chronic inflammatory pathology claim a major share of worldwide deaths each year. A principal reasonbehind the huge number of casualties is associated with mild or unnoticed symptoms for long period of time since the outset, and thatspecific treatment options for these diseases have not yet emerged. Current anti-inflammatory drugs essentially have become ineffectivefor long term protection from these diseases as they also interfere with essential cellular pathways and associated toxicities. Notably, recentstudies with a number of phytochemicals have shown promising results. These compounds isolated from various medicinal plantsexpress their anti-inflammatory activities by down regulating expression of several crucial pro-inflammatory mediators. These are mostlyantioxidants; inhibit induction of key transcription factors like nuclear factor kappa B (NF-κB) that are responsible for expression of proinflammatorymediators, and other growth regulators. Definitely, some of these compounds have the potential to be developed into newtherapeutic agents to better control inflammation associated diseases in near future. This review summarizes recent findings on the molecularmechanisms through which various inflammatory activities are linked to disease progression and a group of natural products thathave shown promise in controlling these processes.

              Export Options

              About this article

              Cite this article as:

              Ghosh Nilanjan, Ali Asif, Ghosh Rituparna, Das Shaileyee, Mandal C. Subhash and Pal Mahadeb, Chronic Inflammatory Diseases: Progress and Prospect with Herbal Medicine, Current Pharmaceutical Design 2016; 22 (2) .https://dx.doi.org/10.2174/1381612822666151112151419

              DOI
              https://dx.doi.org/10.2174/1381612822666151112151419
              Print ISSN
              1381-6128
              Publisher Name
              Bentham Science Publisher
              Online ISSN
              1873-4286

              Call for Papers in Thematic Issues

              31 December, 2025
              Advances in the Molecular Pathogenesis of Inflammatory Bowel Disease.

              This thematic issue will emphasize the recent breakthroughs in the mechanisms of Inflammatory bowel disease (IBD) pathogenesis and devotes some understanding of both Crohn’s and ulcerative colitis. It is expected to include studies about cellular and genetic aspects, which help to precipitate the disease, and the immune system-gut microbiome relations ...read more


              Guest Editor(s): Dr. Manish Gautam
              31 December, 2025
              Blood-based biomarkers in large-scale screening for neurodegenerative diseases

              Disease biomarkers are necessary tools that can be employed in several clinical context of use (COU), ranging from the (early) diagnosis, prognosis, and prediction, to monitoring of disease state and/or drug efficacy. Regarding neurodegenerative diseases, in particular Alzheimer’s disease (AD), a battery of well-validated biomarkers are available, such as cerebrospinal ...read more


              Guest Editor(s):Dr. Carlo Cervellati
              31 December, 2025
              Current Pharmaceutical challenges in the treatment and diagnosis of neurological dysfunctions

              Neurological dysfunctions (MND, ALS, MS, PD, AD, HD, ALS, Autism, OCD etc..) present significant challenges in both diagnosis and treatment, often necessitating innovative approaches and therapeutic interventions. This thematic issue aims to explore the current pharmaceutical landscape surrounding neurological disorders, shedding light on the challenges faced by researchers, clinicians, and ...read more


              Guest Editor(s):Dr. Sidharth Mehan
              31 December, 2025
              Diabetes mellitus: advances in diagnosis and treatment driving by precision medicine

              Diabetes mellitus (DM) is a chronic degenerative metabolic disease with ever increasing prevalence worldwide which is now an epidemic disease affecting 500 million people worldwide. Insufficient insulin secretion from pancreatic β cells unable to maintain blood glucose homeostasis is the main feature of this disease. Multifactorial and complex nature of ...read more


              Guest Editor(s):Dr. Ali Yadollahpour,
              Related Journals

              Anti-Cancer Agents in Medicinal Chemistry

              Anti-Inflammatory & Anti-Allergy Agents in Medicinal Chemistry

              Current Bioactive Compounds

              Current Cancer Drug Targets

              Combinatorial Chemistry & High Throughput Screening

              Current Cancer Therapy Reviews

              Current Diabetes Reviews

              Current Drug Safety

              Current Drug Targets

              Current Drug Therapy

              Related Books

              Andrographolide and its Analogs: Botanical Sources, Phytochemistry, Pharmacology, and Biotechnology

              Anthocyanins: Pharmacology and Nutraceutical Importance

              Herbal Medicine for Autoimmune Diseases

              The Roles and Responsibilities of Clinical Pharmacists in Hospital Settings

              Bioactive Compounds from Medicinal Plants for Cancer Therapy and Chemoprevention

              Drug Addiction Mechanisms in the Brain

              The NLRP3 Inflammasome: An Attentive Arbiter of Inflammatory Response

              Software and Programming Tools in Pharmaceutical Research

              Objective Pharmaceutics: A Comprehensive Compilation of Questions and Answers for Pharmaceutics Exam Prep

              Medicinal Chemistry of Drugs Affecting Cardiovascular and Endocrine Systems

              Article Metrics
              69
              4
              1
              1
              Wayfinder Image
              TIMBC 2025
              Related Articles
              © 2025 Bentham Science Publishers |Privacy Policy

              [8]ページ先頭

              ©2009-2025 Movatter.jp